首頁 > 市場調查報告書 > 醫療設備

體外診斷

血糖試紙市場規模、佔有率及成長分析（按應用、最終用途、技術及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902802

血糖試紙市場規模、佔有率及成長分析（按應用、最終用途、技術及地區分類）－2026-2033年產業預測

Blood Glucose Test Strips Market Size, Share, and Growth Analysis, By Application (Type 1, Type 2), By End Use (Individuals, Hospitals And Clinics), By Technology, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，血糖試紙市場規模將達到 23.5 億美元，到 2025 年將達到 25.7 億美元，到 2033 年將達到 52.8 億美元，在預測期（2026-2033 年）內，複合年成長率為 9.4%。

血糖試紙市場是醫療保健領域的重要組成部分，對有效管理糖尿病至關重要。隨著全球糖尿病盛行率的上升，對血糖試紙的需求持續成長。成年糖尿病患者人數的顯著增加凸顯了定期血糖監測的必要性。近年來，監測技術正朝著更先進的方向發展，例如持續血糖監測（CGM）系統，該系統可提供即時數據，並最大限度地減少對傳統試紙的依賴。然而，即使CGM設備的普及率不斷提高，血糖值試紙仍因其價格實惠、易於使用而成為自我管理的首選，確保其在任何糖尿病護理策略中都扮演著不可或缺的角色。

血糖試紙市場促進因素

受糖尿病管理意識的提高和醫療保健投入的增加，血糖試紙市場正經歷顯著成長。隨著越來越多人意識到糖尿病管理的重要性，血糖值監測設備的普及率也隨之提高。此外，世界各地的醫療機構和政府都將糖尿病的早期發現和有效管理列為優先事項。這項措施提高了血糖值試紙的可及性和使用率，隨著越來越多的人尋求積極主動的措施來維護自身健康，從而促進了整個市場的擴張。

限制血糖試紙市場發展的因素

由於其他血糖監測技術的興起，尤其是持續血糖監測（CGM）系統的出現，傳統血糖試紙市場面臨嚴峻的挑戰。這些先進的系統能夠即時提供血糖值讀數，無需頻繁進行指尖採血，為使用者提供了更便利、更人性化的血糖值監測方式。隨著消費者擴大轉向這些創新解決方案，對傳統血糖試紙的需求可能會下降。這種轉變表明，人們越來越傾向於選擇更全面的血糖管理方案，從長遠來看，這可能會對傳統血糖試紙市場產生負面影響。

血糖試紙市場趨勢

血糖試紙市場正呈現出顯著的成長趨勢，這主要得益於消費者對高效且便利的血糖監測解決方案日益成長的需求，而這又源於持續血糖監測（CGM）系統的廣泛應用。這些先進技術利用皮下感測器提供即時血糖值追蹤，顯著減少了對傳統指尖採血的依賴。隨著消費者越來越重視易用且精準的健康管理工具，CGM系統憑藉其持續監測和改善血糖值管理的能力，正逐漸成為首選。這種轉變不僅簡化了檢測流程，還有助於改善健康狀況。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Abbott Laboratories（USA）
Roche Diagnostics（Switzerland）
Siemens Healthineers（Germany）
Thermo Fisher Scientific（USA）
Danaher Corporation（USA）
Eurofins Scientific（Luxembourg）
Qiagen NV（Netherlands）
Fujifilm Holdings Corporation（Japan）
DiaSorin SpA（Italy）
Bio-Rad Laboratories, Inc.（USA）
Sekisui Medical Corporation（Japan）
Ortho Clinical Diagnostics（USA）
Beckman Coulter, Inc.（USA）
Myriad Genetics, Inc.（USA）
Alere Inc.（USA）
Quest Diagnostics Incorporated（USA）
LabCorp（USA）
BioMerieux SA（France）
ARUP Laboratories（USA）
MSD（Merck & Co., Inc.）（USA）

結論與建議

簡介目錄

Product Code: SQMIG35A2630

Blood Glucose Test Strips Market size was valued at USD 2.35 Billion in 2024 and is poised to grow from USD 2.57 Billion in 2025 to USD 5.28 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).

The blood glucose test strips market is a crucial segment in the healthcare sector, essential for effective diabetes management. With the increasing prevalence of diabetes globally, the demand for these test strips continues to grow. A significant rise in the adult population affected by diabetes underscores the necessity for regular blood glucose monitoring. Recent trends indicate a shift towards advanced monitoring technologies, such as continuous glucose monitoring (CGM) systems, which provide real-time data and minimize the reliance on traditional test strips. However, despite the emerging popularity of CGM devices, blood glucose test strips maintain their status as the favored option for self-monitoring due to their affordability and ease of use, ensuring they remain integral to diabetes care strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Blood Glucose Test Strips market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Blood Glucose Test Strips Market Segments Analysis

Global Blood Glucose Test Strips Market is segmented by Application, End Use, Technology And Region. Based on Application, the market is segmented into diabetes. Based on End Use, the market is segmented into individuals, hospitals and clinics and others. Based on Technology, the market is segmented into glucose dehydrogenase (GDH), glucose oxidase and others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Blood Glucose Test Strips Market

The blood glucose test strips market is experiencing notable growth driven by heightened awareness of diabetes management and rising healthcare investment. As more individuals recognize the importance of managing diabetes, there is a corresponding increase in the adoption of glucose monitoring devices. Additionally, healthcare organizations and governments around the globe are prioritizing the early detection and efficient management of diabetes. This focus has resulted in improved access to and utilization of blood glucose test strips, contributing to the overall expansion of this market as more people seek proactive measures to maintain their health and well-being.

Restraints in the Blood Glucose Test Strips Market

The blood glucose test strips market faces significant challenges due to the emergence of alternative glucose monitoring technologies, especially continuous glucose monitoring (CGM) systems. These advanced systems provide instant glucose readings while eliminating the need for regular fingerstick tests, thereby offering users a more convenient and user-friendly approach to monitoring their glucose levels. As consumers increasingly gravitate towards these innovative solutions, the demand for traditional blood glucose test strips may diminish. This shift highlights the growing preference for comprehensive glucose management options, which could adversely impact the market for conventional test strips in the long run.

Market Trends of the Blood Glucose Test Strips Market

The blood glucose test strips market is witnessing a notable trend towards the growing demand for efficient and convenient glucose monitoring solutions, particularly driven by the rise of continuous glucose monitoring (CGM) systems. These advanced technologies leverage subcutaneous sensors to provide real-time glucose level tracking, significantly reducing the reliance on traditional fingerstick tests. As consumers increasingly prioritize user-friendly and accurate health management tools, CGM systems are emerging as a preferred choice due to their ability to facilitate continuous monitoring and enhance management of blood sugar levels. This shift not only streamlines the testing process but also promotes better health outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Blood Glucose Test Strips Market Size by Application & CAGR (2026-2033)

Market Overview
Type 1
Type 2
Gestational Diabetes
Pre-Diabetes

Global Blood Glucose Test Strips Market Size by End Use & CAGR (2026-2033)

Market Overview
Individuals
Hospitals And Clinics
Others

Global Blood Glucose Test Strips Market Size by Technology & CAGR (2026-2033)

Market Overview
Glucose Dehydrogenase (GDH)
Glucose Oxidase
Others

Global Blood Glucose Test Strips Market Size & CAGR (2026-2033)

North America (Application, End Use, Technology)
- USA
- Canada
Europe (Application, End Use, Technology)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Application, End Use, Technology)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Application, End Use, Technology)
- Brazil
- Rest of Latin America
Middle East & Africa (Application, End Use, Technology)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Medical Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabCorp (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARUP Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MSD (Merck & Co., Inc.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments